Technical Analysis for LNTH - Lantheus Holdings, Inc.

Grade Last Price % Change Price Change
C 87.18 -1.69% -1.50
LNTH closed down 0.46 percent on Friday, June 2, 2023, on 84 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down

Date Alert Name Type % Chg
50 DMA Resistance Bearish -1.69%
Spinning Top Other -1.69%
Calm After Storm Range Contraction -1.69%
Multiple of Ten Bearish Other -1.69%
Oversold Stochastic Weakness -1.69%
50 DMA Resistance Bearish -2.14%
Lower Bollinger Band Touch Weakness -2.14%
Oversold Stochastic Weakness -2.14%
Calm After Storm Range Contraction 0.68%
Stochastic Reached Oversold Weakness 0.68%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 2 hours ago
Fell Below Previous Day's Low about 2 hours ago
Down 1% about 2 hours ago
50 DMA Resistance about 3 hours ago
Up 1% about 3 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Lantheus Holdings, Inc. Description

Lantheus Holdings, Inc. is engaged in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The Company's medical imaging agents are used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. The Company's products include contrast agents and medical radiopharmaceuticals, including technetium generators. The Company's products include DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, Neurolite, Thallium Tl 201, Gallium Ga 67, Gludef, Quadramet and Ablavar. The Company is also engaged in developing agents, such as Flurpiridaz F 18, which is a myocardial perfusion imaging agent; 18F LMI 1195, which is a cardiac neuronal imaging agent, and LMI 1174, which is a vascular remodeling imaging agent.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Disease IBD 50 Chemical Elements Prostate Cancer Heart Failure Medical Imaging Stroke Medical Physics Artery Perfusion Artery Disease Congestive Heart Failure Radiopharmaceuticals Imaging Agent Peripheral Vascular Disease Coronary Artery Disease Gallium Neuron Cardiovascular And Other Diseases Medicinal Radiochemistry Myocardial Perfusion Imaging

Is LNTH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 100.8505
52 Week Low 47.46
Average Volume 911,271
200-Day Moving Average 71.50
50-Day Moving Average 89.26
20-Day Moving Average 95.16
10-Day Moving Average 92.85
Average True Range 3.51
RSI (14) 43.18
ADX 26.99
+DI 22.37
-DI 27.13
Chandelier Exit (Long, 3 ATRs) 90.32
Chandelier Exit (Short, 3 ATRs) 91.84
Upper Bollinger Bands 103.49
Lower Bollinger Band 86.84
Percent B (%b) 0.11
BandWidth 17.50
MACD Line 0.03
MACD Signal Line 1.62
MACD Histogram -1.5875
Fundamentals Value
Market Cap 5.93 Billion
Num Shares 66.9 Million
EPS 0.01
Price-to-Earnings (P/E) Ratio 11083.75
Price-to-Sales 1.87
Price-to-Book 1.71
PEG Ratio 0.61
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 92.35
Resistance 3 (R3) 92.44 91.32 91.73
Resistance 2 (R2) 91.32 90.38 91.27 91.53
Resistance 1 (R1) 89.99 89.80 89.43 89.90 91.32
Pivot Point 88.87 88.87 88.59 88.82 88.87
Support 1 (S1) 87.54 87.93 86.98 87.45 86.02
Support 2 (S2) 86.42 87.35 86.37 85.81
Support 3 (S3) 85.09 86.42 85.61
Support 4 (S4) 85.00